Skip to content

Mirum Pharmaceuticals, Inc. MIRM Raw materials and supplies inventory, gross

Raw materials and supplies inventory, gross at other companies

Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM

Other financials

Income statement

See full
Revenue$159.9M+43.3%
Operating income-$789.5M-5,100%
Net income-$790.2M-5,284%
EPS (diluted)-$13.43-4,377%

Balance sheet

See full
Cash & equivalents$261.5M+43.5%
Total debt$13.5M+56.4%
Total equity$242.5M+4.0%
Total assets$890.9M+29.1%

Cash flow

See full
Operating cash flow-$228.8M-11,566%
CapEx$664.0K+1,520%
Free cash flow-$229.4M-11,360%

Valuation

See full
Market cap$6.53B+152%
Enterprise value$6.28B+162%
P/S11.5×+4.6×

Profitability

See full
Operating margin-139.8%-168pp
Net margin-140.2%-169pp
FCF margin-30.3%

Returns & leverage

See full
Return on equity-335.8%-377pp
Debt / equity0.1×0.0×
Current ratio2.1×-1.1×

Where this comes from

Reported directly by Mirum Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InventoryRawMaterialsAndSupplies.

The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mirum Pharmaceuticals, Inc.'s raw materials and supplies inventory, gross.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mirum Pharmaceuticals, Inc.'s raw materials and supplies inventory, gross?
Mirum Pharmaceuticals, Inc. (MIRM) reported raw materials and supplies inventory, gross of $2.61M in Q1 2026.
How has Mirum Pharmaceuticals, Inc.'s raw materials and supplies inventory, gross changed year-over-year?
Mirum Pharmaceuticals, Inc.'s raw materials and supplies inventory, gross decreased by 13.7% year-over-year, from $3.03M to $2.61M.
What is the long-term trend for Mirum Pharmaceuticals, Inc.'s raw materials and supplies inventory, gross?
Over 2 years (2023 to 2025), Mirum Pharmaceuticals, Inc.'s raw materials and supplies inventory, gross has grown at a -1.7% compound annual growth rate (CAGR), from $3M to $2.9M.